Microglial cells: the main HIV-1 reservoir in the brain

C Wallet, M De Rovere, J Van Assche… - Frontiers in cellular …, 2019 - frontiersin.org
Despite efficient combination of the antiretroviral therapy (cART), which significantly
decreased mortality and morbidity of HIV-1 infection, a definitive HIV cure has not been …

Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs

A Ait-Ammar, A Kula, G Darcis, R Verdikt… - Frontiers in …, 2020 - frontiersin.org
One of the most explored therapeutic approaches aimed at eradicating HIV-1 reservoirs is
the “shock and kill” strategy which is based on HIV-1 reactivation in latently-infected cells …

Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells

HK Liao, Y Gu, A Diaz, J Marlett, Y Takahashi… - Nature …, 2015 - nature.com
To combat hostile viruses, bacteria and archaea have evolved a unique antiviral defense
system composed of clustered regularly interspaced short palindromic repeats (CRISPRs) …

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B …

G Darcis, A Kula, S Bouchat, K Fujinaga… - PLoS …, 2015 - journals.plos.org
The persistence of latently infected cells in patients under combinatory antiretroviral therapy
(cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are …

[HTML][HTML] The reservoir of latent HIV

J Chen, T Zhou, Y Zhang, S Luo, H Chen… - Frontiers in cellular …, 2022 - frontiersin.org
The persistence of latent reservoir of the human immunodeficiency virus (HIV) is currently
the major challenge in curing HIV infection. After HIV infects the human body, the latent HIV …

[PDF][PDF] A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

CN Levy, SM Hughes, P Roychoudhury, DB Reeves… - Cell Reports …, 2021 - cell.com
Quantifying the replication-competent HIV reservoir is essential for evaluating curative
strategies. Viral outgrowth assays (VOAs) underestimate the reservoir because they fail to …

[HTML][HTML] Block and lock HIV cure strategies to control the latent reservoir

CL Ahlenstiel, G Symonds, SJ Kent… - Frontiers in cellular and …, 2020 - frontiersin.org
The HIV latent reservoir represents the major challenge to cure development. Residing in
resting CD4+ T cells and myeloid cells at multiple locations in the body, including sanctuary …

Barriers for HIV cure: the latent reservoir

S Castro-Gonzalez, M Colomer-Lluch… - AIDS research and …, 2018 - liebertpub.com
Thirty-five years after the identification of HIV-1 as the causative agent of AIDS, we are still in
search of vaccines and treatments to eradicate this devastating infectious disease. Progress …

HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads

SL Lamers, R Rose, E Maidji, M Agsalda-Garcia… - Journal of …, 2016 - Am Soc Microbiol
ABSTRACT HIV infection treatment strategies have historically defined effectiveness through
measuring patient plasma HIV RNA. While combined antiretroviral therapy (cART) can …

New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system

V Rojas-Celis, F Valiente-Echeverría, R Soto-Rifo… - Cells, 2019 - mdpi.com
Acquired immunodeficiency syndrome (AIDS) has become one of the most devastating
pandemics in recorded history. The main causal agent of AIDS is the human …